OpenAlex
PricingAboutJobs
Log inGet started
Work

Tofersen in the treatment of SOD1 ALS — a two-year experience from the Polish Early Access Program

HTML PDF

Year: 2026
Type: article
Source: Neurologia i Neurochirurgia Polska
DOI: 10.5603/pjnns.113009
Authors: Magdalena Kuźma-Kozakiewicz, Małgorzata Dorobek, Anna Gruszczak, Justyna Zielińska-Turek, Halina Bartosik-Psujek, Tomasz Garbacz, Kamila Żur-Wyrozumska, Dariusz M. Koziorowski, Justyna Dutkiewicz, Ewa M. Krzyżanowska, Błażej Początek, Agnieszka Migacz, Magdalena A. Koszewicz, Jakub Ubysz, Krzysztof Szabat, Katarzyna Tomicka, Sebastian Student, Anetta Lasek-Bal
Institutions: Medical University of Warsaw, National Medical Institute of the Ministry of Interior and Administration, University of Rzeszów, Jagiellonian University, Medical University of Silesia, Wroclaw Medical University, University of Wrocław, Silesian University of Technology
Language: English

Topic: Amyotrophic Lateral Sclerosis Research
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Keywords: tofersen, antisense therapy, early access program, neurofilament light chain, cerebrospinal fluid biomarkers, ALSFRS-R, disease progression rate, forced vital capacity, treatment-related adverse events, Poland, real-world clinical outcomes, salvage therapy
SDG: Good health and well-being

Open Access status: bronze

Funder: Biogen
OpenAlex ID: W7234046683
FWCI:
Cites: 24
Cited by:
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security